These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Etiopathogenesis of early stages of diabetic nephropathy]. Pynka S; Czekolski S Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):830-5. PubMed ID: 2096378 [No Abstract] [Full Text] [Related]
5. Diabetic kidney disease in the db/db mouse. Sharma K; McCue P; Dunn SR Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1138-44. PubMed ID: 12736165 [TBL] [Abstract][Full Text] [Related]
7. [Predicting diabetic nephropathy]. Mogensen CE; Christensen CK Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537 [No Abstract] [Full Text] [Related]
8. Diabetic nephropathy: pathogenesis and treatment. Adler S; Nast C; Artishevsky A Annu Rev Med; 1993; 44():303-15. PubMed ID: 8476252 [TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy. Jenkin KA; Verty AN; McAinch AJ; Hryciw DH Int J Biochem Cell Biol; 2012 Nov; 44(11):2028-31. PubMed ID: 22842535 [TBL] [Abstract][Full Text] [Related]
10. [Contemporary view on pathophysiology and pathogenesis of diabetic nephropathy. II. Pathogenesis of diabetic nephropathy]. Grzeszczak W; Zukowska-Szczechowska E Pol Arch Med Wewn; 1996 May; 95(5):479-85. PubMed ID: 8848417 [No Abstract] [Full Text] [Related]
12. Drug discovery for diabetic nephropathy: trying the leap from mouse to man. Breyer MD Semin Nephrol; 2012 Sep; 32(5):445-51. PubMed ID: 23062985 [TBL] [Abstract][Full Text] [Related]
13. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Brenner BM; Hostetter TH; Olson JL; Rennke HG; Venkatachalam MA Acta Endocrinol Suppl (Copenh); 1981; 242():7-10. PubMed ID: 6940408 [No Abstract] [Full Text] [Related]
15. Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Border WA; Noble NA Kidney Int; 1998 Oct; 54(4):1390-1. PubMed ID: 9773681 [No Abstract] [Full Text] [Related]
17. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats. Okada M; Takemura T; Yanagida H; Yoshioka K Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091 [TBL] [Abstract][Full Text] [Related]
18. Why should an angiogenic factor modulate tubular structure in diabetic nephropathy? Some answers, more questions. Ziyadeh FN; Wolf G Kidney Int; 2003 Aug; 64(2):758-9. PubMed ID: 12846777 [No Abstract] [Full Text] [Related]
20. Renal structure and function in type 2 diabetic patients with or without diabetic nephropathy. Christensen PK Dan Med Bull; 2004 Feb; 51(1):82-103. PubMed ID: 16009073 [No Abstract] [Full Text] [Related] [Next] [New Search]